Cite
HARVARD Citation
Zhou, X. et al. (2020). Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial. Hematological oncology. 38 (4), pp. 531-540. [Online].